Elm bark
This article was originally published in The Tan Sheet
Executive Summary
FDA tells Henry Thayer & Co. in a June 28 letter that a draft U.S. Pharmacopeia monograph for elm bark is "currently being reviewed for approval" and could possibly be published in USP's Pharmacopeial Forum in November. Henry Thayer, which markets elm bark lozenges for xerostomia, was told by FDA that a USP monograph for elm bark is needed before the ingredient can be included in the final monograph for OTC oral health care products ("The Tan Sheet" Oct. 4, 1993, p. 16)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning